Summary of Significant Accounting Policies (Tables)

12 Months Ended

Mar. 03, 2012

Summary of Significant Accounting Policies

Schedule of revenues

	Year Ended
	March 3, 2012 (53 Weeks)		February 26, 2011 (52 Weeks)		February 27, 2010 (52 Weeks)
Pharmacy sales	$	17,725,645	$	17,036,027	$	17,355,964
Front end sales		8,293,643		8,081,576		8,213,388
Other revenue		101,934		97,304		99,765
	$	26,121,222	$	25,214,907	$	25,669,117

Schedule of principal classes of products

The Company's principal classes of products in fiscal 2012 were the following:

Product Class	Percentage of Sales
Prescription drugs		68.1	%
Over-the-counter medications and personal care		9.8	%
Health and beauty aids		5.2	%
General merchandise and other		16.9	%